Meeder Asset Management’s Twist Bioscience TWST Stock Holding History

Meeder Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,262	Closed	-$19K	–	607
2023 Q1	$19K	Sell	1,262 -64,628	-98%	-$1.43M	﹤0.01%	482
2022 Q4	$1.57M	Buy	65,890 +65,672	+30,125%	+$1.9M	0.14%	155
2022 Q3	$8K	Buy	218 +181	+489%	+$7.69K	﹤0.01%	1427
2022 Q2	$1K	Buy	+37	New	+$1.31K	﹤0.01%	2083
2021 Q4	–	Sell	-3,294	Closed	-$352K	–	2267
2021 Q3	$352K	Sell	3,294 -37	-1%	-$4.24K	0.02%	571
2021 Q2	$444K	Buy	3,331 +1,059	+47%	+$123K	0.02%	542
2021 Q1	$282K	Buy	+2,272	New	+$345K	0.01%	648
2020 Q4	–	Sell	-1,131	Closed	-$87K	–	2225
2020 Q3	$87K	Buy	1,131 +934	+474%	+$58.2K	0.01%	825
2020 Q2	$9K	Sell	197 -1,200	-86%	-$43.1K	﹤0.01%	1362
2020 Q1	$43K	Buy	+1,397	New	+$37.6K	﹤0.01%	967

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Meeder Asset Management's TWST Position: Q2 2023 in Review

Meeder Asset Management sold out of Twist Bioscience (TWST) in Q2 2023, closing a stake of 1,262 shares — an estimated $19K sold.

Meeder Asset Management first reported a position in TWST in Q1 2020 and held it in 10 quarters. The position peaked at $1.57M in Q4 2022. 193 funds tracked by Wall St. Rank hold TWST as of Q2 2023.

Meeder Asset Management reported no remaining Twist Bioscience position as of Q2 2023 after selling out during the quarter.
Meeder Asset Management sold 1,262 Twist Bioscience shares in Q2 2023, an estimated $19K.
Meeder Asset Management first reported a position in Twist Bioscience in Q1 2020 and held it in 10 quarters.
Meeder Asset Management's Twist Bioscience position peaked at $1.57M in Q4 2022.
193 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2023.

Based on Meeder Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.